fluorescein-5-isothiocyanate has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brorholt-Petersen, JU; Faergeman, O; Jensen, HK; Raungaard, B | 1 |
Iwano, C; Matsuyama, K; Matzno, S; Nishikata, M; Yasuda, N | 1 |
Enomoto, S; Fukuda, D; Nagai, R; Sata, M; Shirakawa, I | 1 |
1 trial(s) available for fluorescein-5-isothiocyanate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia.
Topics: Amino Acid Substitution; Antibodies, Monoclonal; Anticholesteremic Agents; Carbocyanines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Data Interpretation, Statistical; Fatty Acids, Monounsaturated; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluvastatin; Heterozygote; Humans; Hyperlipoproteinemia Type II; Indoles; Lipoproteins, LDL; Mutation; Protein Binding; Receptors, LDL; T-Lymphocytes; Triglycerides | 2000 |
2 other study(ies) available for fluorescein-5-isothiocyanate and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry.
Topics: Apoptosis; Atorvastatin; Avidin; Biotin; Cell Line; Cell Separation; Cells, Cultured; Drug Industry; Drug Screening Assays, Antitumor; Fatty Acids, Monounsaturated; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Leukemia; Microscopy, Fluorescence; Necrosis; Pharmaceutical Preparations; Pravastatin; Propidium; Pyridines; Pyrroles; Simvastatin; Time Factors | 2005 |
Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.
Topics: Animals; Bone Marrow Transplantation; Cells, Cultured; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Femoral Artery; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluvastatin; Humans; Immunohistochemistry; Immunosuppressive Agents; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Sirolimus; Time Factors; Tunica Intima; Tunica Media | 2009 |